Frontlight ResearchEarly access
Active, not recruitingNo phase
ASAN Medical Center Aortic Valve Replacement Registry
Key facts
- Who runs it
- Ho-Jin Kim
- Where
- South Korea1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 900 people, planned
- Started
- 1 Dec 2017
- Expected to end
- Jul 2027
- Type of study
- Observational
- Treatments tested
- TAVR
- SAVR
- Record updated
- 2 January 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- All successful transcatheter aortic valve replacement or surgical aortic valve replacement
- Written consent
Who cannot take part
- Infective endocarditis
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study evaluates the effectiveness and safety of surgical aortic valve replacement and transcatheter aortic valve replacement in aortic Stenosis.
The group in the trial
- all aortic stenosis
Treatment: TAVR and SAVR
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Implication of Different ECG Left Ventricular Hypertrophy in Patients Undergoing Transcatheter Aortic Valve Replacement.Journal of the American Heart Association, 2022
- Comparison of Sutureless Bioprosthetic Valve With Surgical or TAVR for Severe Aortic Stenosis.JACC. Asia, 2021
- Incidence, Predictors, and Prognostic Impact of Immediate Improvement in Left Ventricular Systolic Function After Transcatheter Aortic Valve Implantation.The American journal of cardiology, 2021
- Record updated
- 2 January 2026